Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.
Elisa FioritoPatrycja SzybowskaEllen M HaugstenMichal KostasGeir F ØyAntoni WiedlochaSachin SinghSigve NakkenGunhild M MælandsmoJonathan A FletcherLeonardo A Meza-ZepedaJørgen WeschePublished in: British journal of cancer (2022)
Our results pave the way for precision medicine approaches against FGFR4 V550L-driven RMS.
Keyphrases